SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor

詳細情報 詳細情報について

• CRID

  1362544420140727936

• DOI

  10.1007/s10557-017-6725-2

• ISSN

  15737241

  09203206

• Web Site

  http://link.springer.com/content/pdf/10.1007/s10557-017-6725-2.pdf

  http://link.springer.com/article/10.1007/s10557-017-6725-2/fulltext.html

• データソース種別

  • Crossref